Xingshu Li

Title: Xingshu Li: Innovator in Anti-Tumor Drug Development

Introduction

Xingshu Li is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tumor drugs. With a total of 3 patents to his name, his work is recognized for its innovative approaches to cancer treatment.

Latest Patents

Xingshu Li's latest patents include a novel pyrimidine derivative and its preparation process. This invention discloses a method of treating tumors using a unique pyrimidine derivative. The tests conducted at the cellular level on tumor cells expressing c-Met demonstrate that the introduction of a chiral structure, along with the incorporation of deuterium and various atoms or groups such as sulfur, selenium, and sulfoxide, significantly enhances the anti-tumor activities of the compounds. The stability of these anti-tumor compounds is also notably improved.

Career Highlights

Throughout his career, Xingshu Li has worked with notable organizations, including the Guangdong Lewwin Pharmaceutical Research Institute Co., Ltd. and Guangdong Cs-Lewwin Drug Research Co., Ltd. His experience in these companies has allowed him to advance his research and contribute to the development of effective pharmaceutical solutions.

Collaborations

Xingshu Li has collaborated with several professionals in his field, including Xinzi Chen and Wei Yang. These partnerships have fostered a collaborative environment that enhances innovation and research in anti-tumor drug development.

Conclusion

Xingshu Li's contributions to the field of pharmaceuticals, particularly in anti-tumor drug development, highlight his innovative spirit and dedication to improving cancer treatment. His patents reflect a commitment to advancing medical science and providing new solutions for patients.